Patients With Intermittent Claudication Injected With ALDH Bright Cells

Trial ID or NCT#

NCT01774097

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to find out if aldehyde dehydrogenase bright (ALDHbr) cells taken from a patient's bone marrow can be placed safely, via intramuscular injections, into their affected calf and lower thigh muscles and improve blood flow and/or peak walking time in patients experiencing pain associated with blocked blood vessels in the leg.

Official Title

Clinical and MR Imaging Assessments in Patients With Intermittent Claudication Following Injection of Bone Marrow Derived ALDH Bright Cells

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Phillip C. Yang, MD
Phillip C. Yang, MD
Cardiologist
Professor of Medicine (Cardiovascular Medicine)
Nicholas Leeper
Nicholas Leeper
Cardiologist, Vascular medicine specialist
Professor of Surgery (Vascular Surgery) and of Medicine (Cardiovascular)

Contact us to find out if this trial is right for you.

Contact

Fouzia Khan
650-736-1410

View on ClinicalTrials.gov